Inhibition of proliferation and estrogen receptor signaling by peroxisome proliferator-activated receptor γ ligands in uterine leiomyoma

Cancer Research

Volumn 63, Issue 6, 2003, Pages 1221-1227

  Houston, Kevin D ^a   Copland, John A ^b   Broaddus, Russell R ^c   Gottardis, Marco M ^d   Fischer, Susan M ^a   Walker, Cheryl Lyn ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; ANTINEOPLASTIC AGENT; BMS 263990 01 001; CERVONIC ACID; CIGLITAZONE; ESTRADIOL; ESTROGEN RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIRINIXIC ACID; TROGLITAZONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TUMOR CELL LINE; UTERUS MYOMA; WESTERN BLOTTING;

ANIMALS; CELL DIVISION; CHROMANS; DOCOSAHEXAENOIC ACIDS; ESTRADIOL; FEMALE; HUMANS; LEIOMYOMA; LIGANDS; PROSTAGLANDIN D2; PROTEIN ISOFORMS; RATS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; THIAZOLES; THIAZOLIDINEDIONES; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; UTERINE NEOPLASMS;

EID: 0037444286     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Braissant, O., Foufelle, F., Scotto, C., Dauca, M., and Wahli, W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, -β, and -γ in the adult rat. Endocrinology, 137: 354-366, 1996.
2. Kliewer, S. A., Umesono, K., Noonan, D. J., Heyman, R. A., and Evans, R. M. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature (Lond.), 358: 771-774, 1992.
3. Issemann, I., and Green, S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature (Lond.), 347: 645-650, 1990.
4. Zhang, B., Marcus, S. L., Sajadi, F. G., Alvares, K., Reddy, J. K., Subramani, S., Rachubinski, R. A., and Capone, J. P. Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase. Proc. Natl. Acad. Sci. USA, 89: 7541-7545, 1992.
5. Bardot, O., Aldridge, T. C., Latruffe, N., and Green, S. PPAR-RXR heterodimer activates a peroxisome proliferator response element upstream of the bifunctional enzyme gene. Biochem. Biophys. Res. Commun., 192: 37-45, 1993.
6. Vu-Dac, N., Schoonjans, K., Kosykh, V., Dallongeville, J., Fruchart, J. C., Staels, B., and Auwerx, J. Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor. J. Clin. Investig., 96: 741-750, 1995.
7. Elstner, E., Muller, C., Koshizuka, K., Williamson, E. A., Park. D., Asou, H., Shintaku, P., Said, J. W., Heber, D., and Koeffler, H. P. Ligands for peroxisome proliferator-activated receptor γ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proc. Natl. Acad. Sci. USA, 95: 8806-8811, 1998.
8. Sarraf, P., Mueller, E., Jones, D., King, F. J., DeAngelo, D. J., Partridge, J. B., Holden, S. A., Chen, L. B., Singer, S., Fletcher, C., and Spiegelman, B. M. Differentiation and reversal of malignant changes in colon cancer through PPAR γ. Nat. Med., 4: 1046-1052, 1998.
9. Kubota, T., Koshizuka, K., Williamson, E. A., Asou, H., Said, J. W., Holden, S., Miyoshi, I., and Koeffler, H. P. Ligand for peroxisome proliferator-activated receptor γ (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. Cancer Res., 58: 3344-3352, 1998.
10. Fajas, L., Auboeuf, D., Raspe, E., Schoonjans, K., Lefebvre, A. M., Saladin, R., Najib, J., Laville, M., Fruchart, J. C., Deeb, S., Vidal-Puig, A., Flier, J., Briggs, M. R., Staels, B., Vidal, H., and Auwerx, J. The organization, promoter analysis, and expression of the human PPARγ gene. J. Biol. Chem., 272: 18779-18789, 1997.
11. Zhu, Y., Qi, C., Korenberg, J. R., Chen, X. N., Noya, D., Rao, M. S., and Reddy, J. K. Structural organization of mouse peroxisome proliferator-activated receptor γ (mPPAR γ) gene: alternative promoter use and different splicing yield two mPPAR γ isoforms. Proc. Natl. Acad. Sci. USA, 92: 7921-7925, 1995.
12. Buttram, V. C., Jr., and Reiter, R. C. Uterine leiomyomata: etiology, symptomatology, and management. Fertil. Steril., 36: 433-445, 1981.
13. Cramer, S., and Patel, A. The frequency of uterine leiomyomas. Am. J. Clin. Pathol., 94: 435-438, 1990.
14. Chiaffarino, F., Parazzini, F., La Vecchia, C., Chatenoud, L., Di Cintio, E., and Marsico, S. Diet and uterine myomas. Obstet. Gynecol., 94: 395-398, 1999.
15. Chiaffarino, F., Parazzini, F., La Vecchia, C., Marsico, S., Surace, M., and Ricci, E. Use of oral contraceptives and uterine fibroids: results from a case-control study. Br. J. Obstet. Gynaecol., 106: 857-860, 1999.
16. Marshall, L. M., Spiegelman, D., Barbieri, R. L., Goldman, M. B., Manson, J. E., Colditz, G. A., Willett, W. C., and Hunter, D. J. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet. Gynecol., 90: 967-973, 1997.
17. Marshall, L. M., Spiegelman, D., Manson, J. E., Goldman, M. B., Barbieri, R. L., Stampfer, M. J., Willett, W. C., and Hunter, D. J. Risk of uterine leiomyomata among premenopausal women in relation to body size and cigarette smoking. Epidemiology, 9: 511-517, 1998.
18. Parazzini, F., Negri, E., La Vecchia, C., Chatenoud, L., Ricci, E., and Guarnerio, P. Reproductive factors and risk of uterine fibroids. Epidemiology, 7: 440-442, 1996.
19. Adamson, G. D. Treatment of uterine fibroids: current findings with gonadotropin-releasing hormone agonists. Am. J. Obstet. Gynecol., 166: 746-751, 1992.
20. Andreyko, J. L., Marshall, L. A., Dumesic, D. A., and Jaffe, R. B. Therapeutic uses of gonadotropin-releasing hormone analogs. Obstet. Gynecol. Surv., 42: 1-21, 1987.
21. Everitt, J. I., Wolf, D. C., Howe, S. R., Goldsworthy, T. L., and Walker, C. Rodent model of reproductive tract leiomyomata. Clinical and pathological features. Am. J. Pathol., 146: 1556-1567, 1995.
22. Howe, S. R., Everitt, J. L., Gottardis, M. M., and Walker, C. Rodent model of reproductive tract leiomyomata: characterization and use in preclinical therapeutic studies. Prog. Clin. Biol. Res., 396: 205-215, 1997.
23. Walker, C. L., Burroughs, K. D., Davis, B., Sowell, K., Everitt, J. I., and Fuchs-Young, R. Preclinical evidence for therapeutic efficacy of selective estrogen receptor modulators for uterine leiomyoma. J. Soc. Gynecol. Investig., 7: 249-256, 2000.
24. Howe, S. R., Gottardis, M. M., Everitt, J. I., Goldsworthy, T. L., Wolf, D. C., and Walker, C. Rodent model of reproductive tract leiomyomata. Establishment and characterization of tumor-derived cell lines. Am. J. Pathol., 146: 1568-1579, 1995.
25. Howe, S. R., Gottardis, M. M., Everitt, J. I., and Walker, C. Estrogen stimulation and tamoxifen inhibition of leiomyoma cell growth in vitro and in vivo. Endocrinology, 136: 4996-5003, 1995.
26. Howe, S. R., Everitt, J. I., Gottardis, M. M., and Walker, C. Estrogen/antiestrogen responsiveness in an in vivo/in vitro model for myometrial tumorigenesis. Ann. N. Y. Acad. Sci., 761: 373-375, 1995.
27. Fuchs-Young, R., Howe, S., Hale, L., Miles, R., and Walker, C. Inhibition of estrogen-stimulated growth of uterine leiomyomas by selective estrogen receptor modulators. Mol. Carcinog., 17: 151-159, 1996.
28. Tzukerman, M. T., Esty, A., Santiso-Mere, D., Danielian, P., Parker, M. G., Stein, R. B., Pike, J. W., and McDonnell, D. P. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol. Endocrinol., 8: 21-30, 1994.
29. Basu-Modak, S., Braissant, O., Escher, P., Desvergne, B., Honegger, P., and Wahli, W. Peroxisome proliferator-activated receptor/3 regulates acyl-CoA synthetase 2 in reaggregated rat brain cell cultures. J. Biol. Chem., 274: 35881-35888, 1999.
30. Keller, H., Givel, F., Perroud, M., and Wahli, W. Signaling cross-talk between peroxisome proliferator-activated receptor/retinoid X receptor and estrogen receptor through estrogen response elements. Mol. Endocrinol., 9: 794-804, 1995.
31. Sarraf, P., Mueller, E., Smith, W. M., Wright, H. M., Kum, J. B., Aaltonen, L. A., de la Chapelle, A., Spiegelman, B. M., and Eng, C. Loss-of-function mutations in PPAR γ associated with human colon cancer. Mol. Cell, 3: 799-804, 1999.
32. Tsibris, J. C., Porter, K. B., Jazayeri, A., Tzimas, G., Nau, H., Huang, H., Kuparadze, K., Porter, G. W., O'Brien, W. F., and Spellacy, W. N. Human uterine leiomyomata express higher levels of peroxisome proliferator-activated receptor γ, retinoid X receptor α, and all-trans-retinoic acid than myometrium. Cancer Res., 59: 5737-5744, 1999.
33. Hu, E., Kim, J. B., Sarraf, P., and Spiegelman, B. M. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ. Science (Wash. DC), 274: 2100-2103, 1996.
34. Law, R. E., Goetze, S., Xi, X. P., Jackson, S., Kawano, Y., Demer, L., Fishbein, M. C., Meehan, W. P., and Hsueh, W. A. Expression and function of PPARγ in rat and human vascular smooth muscle cells. Circulation, 101: 1311-1318, 2000.
35. Li, S., and McLachlan, J. A. Estrogen-associated genes in uterine leiomyoma. Ann. N. Y. Acad. Sci., 948: 112-120, 2001.
36. Severino, M. F., Murray, M. J., Brandon, D. D., Clinton, G. M., Burry, K. A., and Novy, M. J. Rapid loss of oestrogen and progesterone receptors in human leiomyoma and myometrial explant cultures. Mol. Hum. Reprod., 2: 823-828, 1996.
37. Cramer, S. F., Robertson, A. L., Jr., Ziats, N. P., and Pearson, O. H. Growth potential of human uterine leiomyomas: some in vitro observations and their implications. Obstet. Gynecol., 66: 36-41, 1985.